Please try another search
Alvogen Korea Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. The company offers approximately 200 products. It provides anti-obesity treatment products, such as Furing and Oliet; products in various therapeutic categories, such as nephrology, cardiology, urology, oncology, neurology, endocrinology, and immunology; and incrementally modified and anti-virus drugs. The company offers its products through general hospitals and clinics in various dosage forms comprising tablets, coated tablets, capsules, granules, powders, and sachets. It is also involved in the research and development of fixed dose combination or controlled release, oncology, and CNS treatment drugs. The company was formerly known as Kunwha Pharmaceutical Co., Ltd. and changed its name to Alvogen Korea Co., Ltd. in June 2015. The company was founded in 1958 and is headquartered in Seoul, South Korea. Alvogen Korea Co., Ltd. is a subsidiary of Alvogen Korea Holdings Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review